Verma, Shefali S.
Keat, Karl
Li, Binglan
Hoffecker, Glenda
Risman, Marjorie
,
Sangkuhl, Katrin
Whirl-Carrillo, Michelle
Dudek, Scott
Verma, Anurag
Klein, Teri E.
Ritchie, Marylyn D.
Tuteja, Sony http://orcid.org/0000-0001-7007-3289
Funding for this research was provided by:
National Human Genome Research Institute (U24HG010862)
National Heart, Lung, and Blood Institute (K23HL143161)
Penn Center for Precision Medicine, University of Pennsylvania
Article History
Received: 15 September 2022
Accepted: 30 October 2022
First Online: 28 November 2022
Declarations
:
: The study was approved by the Institutional Review Board of the University of Pennsylvania and complied with the principles set out in the Declaration of Helsinki. All individuals recruited for the Penn Medicine BioBank (PMBB) are patients of clinical practice sites of the University of Pennsylvania Health System. Appropriate consent was obtained from each participant regarding storage of biological specimens, genetic sequencing/genotyping, and access to all available EHR data.
: Not applicable.
: MDR was on the Scientific Advisory Board for Cipherome until June 2022. All other authors declare no competing interests.